UZH-founded skin graft creator Cutiss has welcomed series A investors led by Giammaria Giuliani in a bid to provide improved healing of dermatological scars left by reconstructive or plastic surgery.

Cambridge Material Testing Solutions has been established to develop software and equipment that let industrial clients assess the condition of their metal assets.

UCL and Syncona have both returned for Freeline's series B round, which will spur clinical development of the spinout's gene therapy for haemophilia B.

Raiffeisen and Uniqa have contributed to a fund that will help the firm expand from seed-stage deals to series A and B rounds.

Zurich Insurance has co-led a $17.3m round for insurance technology developer DIG alongside a collaboration agreement.

Wearable sleep tracking device manufacturer Onera has raised an undisclosed sum after spinning off from TNO and nanoelectronics maker Imec.